Research programme: antifungals - Cytokinetics
Latest Information Update: 16 Mar 2009
At a glance
- Originator Cytokinetics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 16 Mar 2009 Discontinued - Preclinical for Mycoses in USA (unspecified route)
- 08 Mar 2004 This programme is available for licensing worldwide (http://cytokinetics.com)
- 14 Jun 2002 Preclinical trials in Mycoses in USA (unspecified route)